Katy has worked in the cell therapy field for over 10 years. Prior to joining Achilles, she was VP of Process Development at Cell Medica Ltd. where she performed the process optimisation and transfer of their first oncology cell product from an academic partner to a CMO, to support the IND filing with the FDA. Katy has extensive experience in developing adoptive cell therapy products and managing their GMP production. Katy holds a Ph.D. in T cell immunology from University College London (ICH) and a BSc in Biochemistry with applied molecular biology from University of Manchester (UMIST
Katy has worked in the cell therapy field for over 10 years. Prior to joining Achilles, she was VP of Process Development at Cell Medica Ltd. where she performed the process optimisation and transfer of their first oncology cell product from an academic partner to a CMO, to support the IND filing with the FDA. Katy has extensive experience in developing adoptive cell therapy products and managing their GMP production. Katy holds a Ph.D. in T cell immunology from University College London (ICH) and a BSc in Biochemistry with applied molecular biology from University of Manchester (UMIST